Clinical laboratory tests associated with survival in patients with metastatic renal cell carcinoma: A Laboratory Wide Association Study (LWAS)

CONCLUSIONS: Routinely measured laboratory tests can refine current prognostic models, facilitate comparisons across clinical trial cohorts, and match patients with specific systemic therapies.PMID:34580027 | DOI:10.1016/j.urolonc.2021.08.011

Source: Urologic Oncology - September 28, 2021 Category: Urology & Nephrology Authors: Kyla Velaer I-Chun Thomas Jaden Yang Kristopher Kapphahn Thomas J Metzner Abhinav Golla Christian R Hoerner Alice C Fan Viraj Master Glenn M Chertow James D Brooks Chirag J Patel Manisha Desai John T Leppert Source Type: research